News | Solas BioVentures

2019

Baebies Founders’ Report 2019

DEC 18, 2019

Learn More

Renovia Announces FDA 510(k) Clearance of Next-Generation leva® Pelvic Digital Therapeutic

NOV 25, 2019

Learn More

Solas BioVentures Co-Founder David Adair, M.D. Joins Mayfield Pharmaceuticals Board of Directors

OCT 23, 2019

Learn More

Renovia Study Results Published in Neurourology and UrodynamicsShow Positive Results for leva® Pelvic Digital Therapeutic in Treating Female Urinary Incontinence

AUG 7, 2019

Learn More

Transomic CRISPR Library to be Implemented at the Victorian Centre for Functional Genomics

MAY 16, 2019

Learn More

AEGEA Medical Completes Enrollment in PACE MX, the Third Study Assessing Long-Term Access to the Uterine Cavity after Endometrial Ablation with Water Vapor

APR 22, 2019

Learn More

David Adair, Managing Director of Solas BioVentures, Joins Panel on De-risking Medtech Innovation at SEMDA 2019 Conference

APR 9, 2019

Learn More

Transomic CRISPR library to be implemented at UCLA

APR 5, 2019

Learn More

Breakthrough Innovation: The HAART Aortic Annuloplasty Device Cleared by the FDA (BioStable S&E)

APR 3, 2019

Learn More

Eight Teams in CO.LAB's Inaugural “HealthTech Accelerator” Unveiled at Chattanooga Event (PreTel)

APR 2, 2019

Learn More

Renovia Inc. Nominated for MedTech Company of the Year at the New England Venture Capital Association’s 2019 NEVYs Awards

MAR 28, 2019

Learn More

St. Louis Medical Device Startup Elira Inc. Raises Over $900K in Debt Offering

MAR 19, 2019

Learn More

Is Chattanooga the Sweet Spot for Early Stage Medtech Innovators? (SEMDA)

MAR 18, 2019

Learn More

Duke Engineering Program Adds Entrepreneur-in-Residence (Baebies)

MAR 12, 2019

Learn More

Procedure in Indiana Provides Important New Option for Heart Valve Repair (BioStable S&E)

FEB 22, 2019

Learn More

Transomic CRISPR library to be implemented at McGill University

FEB 13, 2019

Learn More

Three Chattanooga Startups Win Grants from Tennessee's Business Development Agency (PreTel Health)

JAN 8, 2019

Learn More

AEGEA Medical Completes Enrollment in the Pace II Clinical Trial

JAN 7, 2019

Learn More